NONO promotes hepatocellular carcinoma progression by enhancing fatty acids biosynthesis through interacting with ACLY m
- PDF / 5,515,031 Bytes
- 16 Pages / 595.276 x 790.866 pts Page_size
- 87 Downloads / 206 Views
PRIMARY RESEARCH
Cancer Cell International Open Access
NONO promotes hepatocellular carcinoma progression by enhancing fatty acids biosynthesis through interacting with ACLY mRNA Hongda Ding , Junpeng Liu, Caibin Wang and Yang Su*
Abstract Background: Dysregulation of fatty acid (FA) metabolism is involved in hepatocellular carcinoma (HCC) development. Non-POU domain-containing octamer binding protein (NONO), known as the component of nuclear paraspeckles, has recently been found to promote HCC progression. In this study, we investigated the functions of NONO in regulating de novo FA synthesis and its underling mechanism during HCC development. Methods: The roles of NONO in HCC development by applying gene function loss analysis in HCC cells were detected by quantitative real-time polymerase chain reaction, cell proliferation, and cell invasion assays. The underlying mechanism of NONO in HCC development was examined by western blotting, subcellular fractionation, RNAbinding protein immunoprecipitation-sequencing, chromatin immunoprecipitation, co-immunoprecipitation and mass spectrometry. The effect of NONO on tumorigenesis in vivo was performed with a subcutaneous xenograft mouse model of HCC. Results: NONO promotes HCC progression by interacting with and increasing ATP-citrate lyase (ACLY) mRNA to enhance FA biosynthesis. Furthermore, NONO promotes ACLY expression through enhancing nuclear ACLY mRNA stability in Diethylnitrosamine-stimulated HCC cells, not related to nuclear paraspeckles. Moreover, we find that NONO/ SFPQ (Splicing factor proline and glutamine rich) heterodimer is essential for NONO interacting with ACLY mRNA in DEN stimulated HCC cells. In addition, NONO, Insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) and ACLY expressions contribute HCC development in mice and are related to poor survival. Conclusion: NONO promotes HCC progression by enhancing FA biosynthesis through interacting with ACLY mRNA and provide a novel potential target for HCC therapy. Keywords: Hepatocellular carcinoma, Non-POU domain-containing octamer binding protein, Fatty acid biosynthesis, ATP-citrate lyase, Insulin like growth factor 2 mRNA binding protein 1 Background Hepatocellular carcinoma (HCC) is a highly aggressive solid tumor with poor prognosis and high mortality worldwide [1, 2]. It is estimated that over 700,000 *Correspondence: [email protected] Department of General Surgery, Shengjing Hospital of China Medical University, No. 36 Sanhao Road, Shenyang 110004, China
deaths caused by HCC every year globally [3]. Although great progress of HCC therapy, 5-year survival of HCC patients after therapy is still only below 30% [4]. Nowadays, emerging studies report that fatty acids (FA) biosynthesis functions essential role in HCC progression [5–8]. Therefore, clarifying the molecular mechanism of lipid biosynthesis in HCC tumorigenicity and
© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distributi
Data Loading...
